|
BRD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.384250E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.53299999980672E-07 |
| Normal-vs-Stage2 |
5.751100E-04 |
| Normal-vs-Stage3 |
8.806400E-02 |
| Normal-vs-Stage4 |
5.127900E-02 |
| Stage1-vs-Stage2 |
5.948200E-01 |
| Stage1-vs-Stage3 |
1.861960E-02 |
| Stage1-vs-Stage4 |
3.552800E-01 |
| Stage2-vs-Stage3 |
2.226000E-01 |
| Stage2-vs-Stage4 |
6.443400E-01 |
| Stage3-vs-Stage4 |
6.415800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.04569999999737E-05 |
| Normal-vs-AfricanAmerican |
1.16059999999418E-06 |
| Normal-vs-Asian |
2.230200E-02 |
| Caucasian-vs-AfricanAmerican |
3.097600E-01 |
| Caucasian-vs-Asian |
8.437600E-01 |
| AfricanAmerican-vs-Asian |
9.029800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.66289999945246E-07 |
| Normal-vs-Female |
6.060400E-02 |
| Male-vs-Female |
2.883000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.248680E-04 |
| Normal-vs-Extreme_Weight |
1.13899999998335E-06 |
| Normal-vs-Obese |
1.620270E-02 |
| Normal-vs-Extreme_Obese |
3.438000E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.370800E-01 |
| Normal_Weight-vs-Obese |
7.825900E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.595200E-01 |
| Extreme_Weight-vs-Obese |
1.879790E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.448200E-01 |
| Obese-vs-Extreme_Obese |
3.013900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.231000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.818920E-03 |
| Normal-vs-Age(61-80Yrs) |
2.01660000032078E-07 |
| Normal-vs-Age(81-100Yrs) |
2.64999999999294E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.803700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.259500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.758020E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.798700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.612430E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.763240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.95053999999528E-05 |
| Normal-VS-Type2 PRCC |
2.16709999945053E-08 |
| Normal-VS-KIRP CIMP |
2.075400E-01 |
| Normal-VS-Unclassified PRCC |
1.441800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.264100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.274000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.433980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.261710E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.103900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.977700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.45470000045833E-07 |
| Normal-vs-N1 |
7.227400E-01 |
| Normal-vs-N2 |
9.822400E-01 |
| N0-vs-N1 |
1.288150E-02 |
| N0-vs-N2 |
2.966200E-01 |
| N1-vs-N2 |
9.009200E-01 |
|
|
